Benda Pharmaceutical appoints chief operating officer
This article was originally published in Scrip
Executive Summary
Benda Pharmaceutical, a China-based pharmaceutical company producing Gendicine, a commercialised gene therapy medicine for the treatment of cancer, and traditional Chinese and conventional medicines, has appointed George Zhou chief operating officer. Mr Zhou was previously a partner and managing director of Eos Funds, where he directed investments in Chinese companies which intended to list on US and Canadian exchanges.